HoLEP is a minimally invasive procedure that offers immediate relief from symptoms of benign prostatic hyperplasia (BPH)
Benign prostatic hyperplasia, or BPH, is a non-cancerous condition that occurs when the prostate enlarges and constricts or obstructs urine flow.
BPH affects nearly half of men over age 50 and approximately 80% of men in their 80s.
Holmium Laser Enucleation of the Prostate (HoLEP) is a minimally invasive procedure to treat BPH, which gives patients immediate improved urine flow, in addition to long-term prostate relief.
How does HoLEP work?
- The HoLEP procedure uses a laser that targets the portion of the enlarged prostate that is affecting urine flow
- To relieve the symptoms of BPH, the laser slices that portion of the enlarged prostate into small, easily removable pieces
HoLEP procedure advantages
- Ability to treat any size prostate gland with minimal bleeding
- A re-treatment rate of less than 2%
- Early, immediate relief of BPH symptoms and fast return to normal activity. Patients usually go back to work within two to three days and can resume their physical exercise within two weeks
- Next-day catheter removal in most of the cases, with less than a 24-hour hospital stay
- Minimal pain, requiring only oral pain control
- Fewer potential complications. The holmium laser technology offers a low-depth of penetration of less than half of 1 mm, which causes less damage to the underlying healthy tissue and lowers the risk for excessive bleeding